Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction
Anne-Laure Leblond, John O’Sullivan, Noel Caplice1Centre for Research in Vascular Biology (CRVB), Biosciences Institute, University College Cork, Cork, IrelandAbstract: Despite advances in the management of myocardial infarction, congestive heart failure following myocardial infarction...
Guardado en:
Autores principales: | Anne-Laure Leblond, John O’Sullivan, Noel Caplice |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f06cc6aac9c4480c986f918d30eff0fe |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
M1 Bone Marrow-Derived Macrophage-Derived Extracellular Vesicles Inhibit Angiogenesis and Myocardial Regeneration Following Myocardial Infarction via the MALAT1/MicroRNA-25-3p/CDC42 Axis
por: Bairong Chen, et al.
Publicado: (2021) -
Hematopoietic stem cells: ex-vivo expansion and therapeutic potential for myocardial ischemia
por: Jingwei Lu, et al.
Publicado: (2010) -
Human adipose stem cell and ASC-derived cardiac progenitor cellular therapy improves outcomes in a murine model of myocardial infarction
por: Davy PMC, et al.
Publicado: (2015) -
Autologous bone marrow cell therapy for peripheral arterial disease
por: Botti C, et al.
Publicado: (2012) -
Stem cell technology for bone regeneration: current status and potential applications
por: Asatrian G, et al.
Publicado: (2015)